
VivoSim Labs Stock Reverses Gains Despite $5 Million Eli Lilly Milestone
VivoSim Labs (VIVS) shares fell in after-hours trading, erasing a sharp intraday rally that followed news of a $5 million milestone payment from Eli Lilly. The reversal was driven by profit-taking amid the company's weak underlying financials and high short interest.







